Introduction
Human T-cell leukemia virus type 1 (HTLV-1), a human retrovirus, is the causative agent of adult T-cell leukemia (ATL), an aggressive malignancy of CD4 þ T lymphocytes. HTLV-1 is also closely related to HTLV-1-associated myelopathy or tropical spastic paraparesis (HAM/TSP) (Uchiyama, 1997) . Although most HTLV-1-infected people are nonsymptomatic, approximately 4% of patients develop ATL after a long period of latent infection (over 50 years). To date, there are few effective therapies available for ATL patients, possibly due to a lack of detailed information about the molecular mechanism of cell growth regulation by HTLV-1.
The HTLV-1 genome encodes the common structural and enzymatic proteins typical of all retroviruses (i.e. Gag, Pol, and Env) and the regulatory and accessory proteins (i.e. Tax, Rex, p12 I , p27
I , p13 II , and p30 II ) (Albrecht and Lairmore, 2002) . Among these, Tax is postulated to play a pivotal role in the development of ATL, since it has the capacity to immortalize human T cells (Grassmann et al., 1992; Akagi and Shimotohno, 1993) , transform rat fibroblasts (Pozzatti et al., 1990; Tanaka et al., 1990) , and induce tumors in Taxtransgenic mice. Tax is thought to induce these effects through the modulation of the cellular transcriptional machinery. Tax enhances the transcription of genes with cyclic AMP responsive element (CRE), nuclear factorkB (NF-kB) element, CArG box, and activating protein-1 (AP-1) sites on their promoters and, conversely, represses p53 function, resulting in the impairment of p53-dependent gene expression. Previous reports show that Tax induces the expression of AP-1 family proteins, such as JunB, c-Jun, JunD, c-Fos, and Fra-1 (Fujii et al., 1988 (Fujii et al., , 1991 Hooper et al., 1991) , and T-cell lines transformed by HTLV-1 display high levels of AP-1 activity (Mori et al., 2000; Iwai et al., 2001) . However, the precise mechanism of regulation of AP-1 activity in HTLV-1-infected cells still remains to be addressed.
Various physiological and environmental stimuli induce AP-1 activity, and it is involved in a variety of cellular events including proliferation, apoptosis, differentiation, and tumorigenesis. AP-1 functions not as a single protein, but as a dimer comprised of basic leucinezipper (bZIP) proteins from the Jun family (c-Jun, JunB, JunD), Fos family (c-Fos, FosB, Fra-1, Fra-2) and others. AP-1 recognizes a consensus element (5 0 -TGAG/ CTCA-3 0 ) known as the AP-1 site, which is present on the promoter regions of many genes induced by inflammatory stimuli. Among the AP-1 components, c-Jun and c-Fos are the most potent transactivators. The transcriptional activity and protein stability of c-Jun are regulated largely through covalent modifications. For example, phosphorylation of c-Jun by Jun N-terminal kinase (JNK), a member of the MAP kinase family, results in a dramatic increase in the transcriptional activity of c-Jun (Derijard et al., 1994) . In addition, ubiquitination of c-Jun causes its decreased stability through ubiquitin-dependent proteolysis (Treier et al., 1994) .
Recently, the novel viral protein HTLV-1 bZIP factor (HBZ), which is encoded in the complementary strand of the HTLV-1 genome, has been identified. The minus stranded RNA of the HTLV-1 genome that corresponds to the HBZ coding region accumulates in an HTLV-1-infected T-cell line, SLB1 (Larocca et al., 1989) , and HBZ protein expression is also observed in HTLV-1-infected cell lines, MT-4 and C8166 (Gaudray et al., 2002) . HBZ is a nuclear protein composed of 209 amino acids that possesses a transactivation domain and a conserved bZIP region in its N-and C-terminus, respectively. HBZ interacts with ATF-4, and this interaction abolishes the ability of ATF-4 to bind to the Tax responsive element (TxRE), resulting in the repression of transcription from the HTLV-1 long terminal repeat (LTR) (Gaudray et al., 2002) . Moreover, HBZ inhibits activation of a gene containing AP-1 on the promoter by c-Jun but enhances the transcription function of JunB and JunD (Basbous et al., 2003; Thebault et al., 2004) . HBZ suppresses c-Jun activity through inhibiting c-Jun DNA-binding. In the course of further analysis of the functional regulation of c-Jun by HBZ, we observed that HBZ not only suppresses the DNA-binding activity of c-Jun but also reduces its stability via a proteasome-dependent pathway.
Results

HBZ represses c-Jun-mediated transactivation through two distinct mechanisms
To characterize the function(s) of HBZ, we performed yeast two-hybrid screen using full-length of HBZ as bait.
The coding region of HBZ was subcloned into pGBT9 vector (Clontech, GAL4 system), and this plasmid was cotransformed with human fetal brain cDNA library (Clontech) into yeast cell line, Y190. Consistent with previous reports by another group (Basbous et al., 2003; Thebault et al., 2004) , we also identified Jun proteins (JunB, c-Jun, and JunD) as cellular targets of HBZ. We focused on c-Jun protein and investigated the effect of HBZ on c-Jun function. It has been reported that HBZ represses c-Jun-mediated transcription of collagenase, a gene containing an AP-1 element in the promoter (Basbous et al., 2003) . To analyse the effect of HBZ on the transcriptional activity of c-Jun more precisely, we conducted reporter gene analysis using pAP-1-Luc, which has seven repeats of the AP-1 element upstream of a minimal promoter. In HEK-293 T cells, exogenous expression of c-Jun stimulated luciferase activity by 50-fold relative to the basal level ( Figure 1b , lane 6), and coexpression of HBZ dramatically repressed this activity in a dose-dependent manner (lanes 7-10), confirming that HBZ represses c-Jun-mediated AP-1 activation. Similar result was also obtained with HeLa cells (data not shown). It is known that HTLV-1 Tax stimulates AP-1-mediated transcription (Iwai et al., 2001; Mori et al., 2000) . In order to determine the role of HBZ in transformation by HTLV-1, we investigated whether HBZ affects Tax-induced AP-1 activation. Thus, we performed reporter assay with a reporter plasmid containing 2 Â AP-1 elements (Mukaida et al., 1994) using human T-cell line, Jurkat. As shown in Figure 1c , Tax stimulated luciferase activity by 2.7-fold, and additional expression of HBZ repressed the activity to 1.6-fold. This result suggests that HBZ has the ability to suppress Tax-induced AP-1 activation. Next, we wished to determine the region of HBZ responsible for the transcriptional repression. To this end, HBZ deletion mutants as shown in Figure 1a , HBZ-N (1-120 amino acids), HBZ-C (121-209 amino acids), and HBZ-DLZ (lacking leucine-zipper region), were tested. As shown in Figure 1d , HBZ-C showed some suppressive activity (lane 9), while HBZ-N and HBZ-DLZ did not significantly inhibit transcription (lanes 8 and 10), indicating that the leucine-zipper region of HBZ is required for its suppressive function. However, the suppressive effect of HBZ-C was much lower than that of full length HBZ (lane 7 vs 9). The fact that GST-HBZ-C decreased the DNA-bound c-Jun proteins in DNA affinity precipitation assay (Figure 1e ), suggests that the C-terminal Since previous reports showed that c-Jun is degraded via a proteasome-dependent pathway (Treier et al., 1994) , a proteasome inhibitor, MG132, was added to the culture medium to analyse whether this pathway was responsible for the decrease of c-Jun levels. As shown in lanes 4-6, the level of c-Jun was increased and was not significantly different between the lanes, suggesting abrogation of the reduction of c-Jun by HBZ in the presence of the proteasome inhibitor. These observations were also reproducible in HeLa cells (data not shown). These results indicate that proteasome activity is required for the HBZ-mediated decrease in c-Jun protein levels. In addition, we observed that MG132 treatment caused an increase in both HBZ and HBZ-DLZ steady-state levels, suggesting that HBZ is also degraded in a proteasome-dependent manner ( Figure HBZ has no effect on the expression levels of c-Fos protein
In contrast to c-Jun, c-Fos, another component of AP-1, was not isolated by yeast two-hybrid screening using HBZ as bait. Since c-Fos possesses a bZIP domain, we asked whether there is any discrimination in recognition of a bZIP domain by gluthathione S-transferase (GST) pull-down assay. GST-fused HBZ-C interacted with in vitro-translated c-Jun, but not with c-Fos (Figure 4a , top and middle panels, respectively), indicating a specific interaction between HBZ and c-Jun. The molecular interaction of HBZ with c-Jun might alter the mutual subcellular localization. Thus, we examined the cellular localization of HBZ and c-Jun/c-Fos in transiently transfected HeLa cells. As previously reported (Gaudray et al., 2002) , GFP-HBZ localized to the nucleus as granular speckles (Figure 4b, panel 1) . However, when GFP-HBZ and c-Jun were coexpressed, GFP-HBZ no longer formed speckles but was diffusely distributed throughout the nucleus (panel 3). In contrast, c-Fos, which was unable to associate with HBZ (Figure 4a ), did not affect GFP-HBZ localization (panel 7), suggesting that a physical interaction with c-Jun alters the distribution of HBZ. Our observations are not consistent with the previous report, that showed that GFP-HBZ colocalized with c-Jun and JunB in nuclear speckles in COS-7 cells (Basbous et al., 2003) . Although we do not know the reason for this discrepancy, it may be due to cell line variation and/or protein expression levels. Next, we investigated whether HBZ expression also affects the protein levels of c-Fos. As shown in Figure 4c , the levels of c-Fos protein were not decreased by the coexpression of HBZ nor HBZ-DLZ (lanes 1-3), indicating that the reduction of c-Jun proteins by HBZ observed in Figure 2a did not result from a non-specific effect of HBZ. To compare the effect of HBZ on c-Jun stability in the presence of c-Fos, we performed pulsechase analysis and the data are shown in Figure 4d None of these affected the levels of c-Jun protein (Figure 5a , lanes 3 to 5). Thus, we further analysed another four mutants: HBZ-DN100, -DN60, -N60 þ C, and -N60 þ LZ. HBZ-DN100 and -DN60 are N-terminal truncated mutants of HBZ (Figure 1a ). HBZ-N60 þ C and -N60 þ LZ are mutants that contain both N-and Cterminal regions of HBZ but lack the internal region ( Figure 1a) . As HBZ-N60 þ LZ did not localize to the nucleus (data not shown), the nuclear localization signal (NLS) derived from simian virus 40 (SV40) large T antigen was fused to the N-terminus of HBZ-N60 þ LZ. Although gradual extension of the internal regions of HBZ (HBZ-C, -DN100, and -DN60) did not affect the levels of c-Jun (Figure 5a, lanes 8-10) , HBZ-N60 þ C
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RT ( and -N60 þ LZ reduced the levels (lanes 11 and 12). These results suggest the requirement of the N-terminal plus leucine-zipper domains of HBZ for suppression of c-Jun. The immunoprecipitation experiment showed that HBZ mutants containing leucine-zipper associated with c-Jun (Figure 5b, lanes 2, 4, and 6-8 ), but others did not (lanes 3 and 5). Since HBZ-C and HBZ-DN60 were able to associate with c-Jun, but failed to reduce the levels of c-Jun, these results imply that the reduction in c-Jun protein by HBZ requires not only association but also an additional function of HBZ through its N-terminal region. Next, to investigate the effect of reduction of c-Jun on AP-1 transcriptional activity, a reporter assay was conducted and its result is shown in . Whereas HBZ-C and -DN60 repressed c-Junmediated transcription to some extent (lanes 4 and 5), two HBZ mutants, HBZ-N60 þ LZ and -N60 þ C, suppressed transcription as effectively as that by fulllength HBZ (lanes 3, 6, and 7), indicating that full transcriptional repression by HBZ requires both the N-terminal and leucine-zipper regions of HBZ. These data strongly suggest that HBZ represses c-Jun transcriptional activity by two independent mechanisms: decreasing DNA-binding ability and reducing the stability of c-Jun protein.
Discussion
In this study, we demonstrated that HBZ specifically interacted with c-Jun and dramatically suppressed c-Jun-induced transcriptional activation from the AP-1 element ( Figure 1b ). This transcriptional repression by HBZ is mediated, in part, by decreasing the DNAbinding activity of c-Jun (Figure 1e and f) as previously reported by other group (Basbous et al., 2003) . However, we found additional evidence that HBZ potentially decreases the steady-state level of c-Jun and reduces the stability of c-Jun protein in cells (Figures 2  and 3 ). The reduction of c-Jun protein by HBZ was prevented by the treatment of proteasome inhibitors, but not calpain inhibitor, indicating that the reduction of c-Jun by HBZ occurs through a proteasomedependent pathway (Figure 2 ). Thus, we suggest the presence of an additional novel function of HBZ to inhibit c-Jun activity. In a reporter assay, full-length HBZ strikingly repressed the trans-acting function of c-Jun (Figure 1b) , but HBZ-C, which has the potential to interact with c-Jun (Figure 4a ) and to reduce DNA-binding ability of c-Jun (Figure 1e ), did not cause full transcriptional repression (Figure 1d ). In addition, HBZ-C did not affect the level of c-Jun protein (Figure 5a ). These observations led us to consider that the marked suppression of the transcription by full-length HBZ was a result of the impairment of, at least, two functions: the DNA-binding activity and the stability of c-Jun. Further analysis using deletion mutants in Figure 5a suggests that the N-terminal region of HBZ is responsible for the destabilization of c-Jun. This evidence strongly supports the dual effect of HBZ on regulation of c-Jun function.
Virally encoded oncogenic proteins are known to play multiple roles to dysregulate various cellular mechanisms through decreasing the activity of cellular target proteins. For example, HPV type-16 E6 protein utilizes two approaches to inhibit p53 activity: downregulation of p53 protein levels through enhancing p53 ubiquitination and degradation (Scheffner et al., 1993) , and repression of p53 transcriptional activity by sequestering the p53-binding transcriptional coactivators, CBP/p300 (Zimmermann et al., 1999) . Human immunodeficiency virus type-1 (HIV-1) Vif protein targets APOBEC3G, a potent cellular antiretroviral factor, through triggering the accelerated degradation of this protein and impairing the translational potential of APOBEC3G mRNA (Stopak et al., 2003) . In the case of HBZ, we demonstrated that the function of c-Jun was inhibited by two different mechanisms as described above. However, it remains to be elucidated how HBZ reduces c-Jun protein levels through the proteasome pathway. It is unlikely that HBZ directly enhances the proteolysis activity of proteasomes because HBZ does not affect the protein level of c-Fos (Figure 4c) , which is also known to be degraded by the proteasome. Instead, we hypothesize that HBZ accelerates the turnover of cJun through enhancing c-Jun ubiquitination. HBZ may directly recruit a ubiquitin E3 ligase to the complex with c-Jun. There are an increasing number of viral proteins including adenovirus E1B55k-E4orf6 (Querido et al., 2001) , HIV Vif (Yu et al., 2003) , and HPV E6 (Huibregtse et al., 1991) , which recruit E3 complexes to enhance the ubiquitination of target proteins. We observed that HBZ downregulates the protein levels of its interacting protein, c-Jun (Figure 2a ), but not a nonbinding protein, c-Fos (Figure 4c ). In addition, other HBZ-interacting proteins obtained by yeast twohybrid screen were also downregulated by coexpression with HBZ (data not shown). These observations led us to consider the possibility that HBZ recruits E3 complexes as its binding partner, resulting in ubiquitination and entry into the proteasome degradation pathway. In this regard, the N-terminal region of HBZ (1-60 amino acids) may function as an E3-recruiting site since this region is required for the elimination of c-Jun (Figure 5a ). Further clarification of the roles of HBZ in We showed that HBZ has a potential to induce c-Jun degradation in cells (Figure 2) , inconsistent with previous report that the levels of c-Jun protein are elevated in HTLV-1-infected cell lines (Fujii et al., 1991; Hooper et al., 1991) . We observed that Tax enhanced the activation of AP-1 transcription in Jurkat cells, and ectopic expression of HBZ into this Tax-expressing Jurkat cells significantly reduced the AP-1 activity (Figure 1c) . However, we still observed that about a half of the activity remained under this condition. From this result, we speculate that HBZ reduces the level of cJun that is up-regulated by Tax in HTLV-1-infected cells significantly but not all the level. Furthermore, it is also likely that the low expression of HBZ in HTLV-1-infected cell lines (Gaudray et al., 2002) is not sufficient to suppress c-Jun level to the level of normal cells.
Since AP-1 has been implicated in the tumorigenesis and transformation of T cells, inappropriate activation of AP-1 could contribute to the dysregulated phenotypes of HTLV-1-infected cells or the development of ATL. Indeed, HTLV-1-infected cell lines have high AP-1 activity with elevated levels of mRNAs encoding AP-1 components (c-Fos, JunB, JunD, c-Fos, Fra-1, etc.) (Fujii et al., 1991; Hooper et al., 1991) , some of which are also induced by Tax. In addition, it has been reported that AP-1-like elements are responsive to Tax in several genes involved in cell growth promotion, such as proenkephalin (Fu et al., 1997) , interleukin-2 (Curtiss et al., 1996) , interleukin-5 (Yamagata et al., 1997 ), interleukin-8 (Mori et al., 1998 and TIMP1 (Uchijima et al., 1994) . The findings in this report suggest the intrinsic mechanism of regulation of c-Jun by HBZ and Tax in HTLV-1-infected cells: downregulation and upregulation of c-Jun function by HBZ and Tax, respectively, which may contribute to regulate cell proliferation. Knowing the physiological significance of AP-1 suppression by HBZ may help us to understand the pathogenesis of HTLV-1.
Materials and methods
Cell culture
HEK-293T and HeLa cells were cultured in Dulbecco's modified Eagle's medium (DMEM, Nissui) supplemented with 10% fetal bovine serum (FBS, Invitrogen), 4 mM L-glutamine, and 0.1 mg/ml of kanamycin sulfate. Jurkat cells were cultured in RPMI 1640 (Nissui) supplemented with 10% FBS, 2 mM Lglutamine, and 0.1 mg/ml of kanamycin sulfate. These cells were maintained at 371C in 5% CO 2 atmosphere. Proteasome inhibitors, such as MG132, MG115, PSI, and lactacystin, were purchased from Peptide Institute, and calpain inhibitor II was from Nacalai Tesque.
TATCTGTA-3
0 (forward), 5 0 -AAACTCGAGTTATTGCAA CCACATCGC-3 (reverse). Bold letters in the primers denote restriction sites. The fragment was subcloned into pcDNA3-Flag and pEGFP-C1 (Clontech). Expression plasmids for HBZ deletion mutants ( Figure 1a) were generated by PCR using pcDNA3-HBZ as a template. These fragments were subcloned into vectors such as pcDNA3-Flag and pGEX-6P-1 (Amersham). The cDNAs encoding human c-Jun and c-Fos were amplified by RT-PCR from total RNA from MT-2 cells, and subcloned into pcDNA3-Flag, pcDNA3-HA, and pGEX-6P-1. Primer sequences used were as follows: human c-Jun, 5 0 -AAAGAATTCATGACTGCAAAGATGGAAACG-3 0 (forward), 5 0 -AAACTCGAGTCAAAATGTTTGCAACTGCTG-3 0 (reverse); human c-Fos, 5 0 -AAAGAATTCATGATGTTCT CGGGCTTCAAC-3 0 (forward), 5 0 -AAACTCGAGTCACA GGGCCAGCAGCGT-3 0 (reverse). To construct pcDNA3-cJun-Myc, PCR was performed with a reverse primer lacking stop codon and the fragment was subcloned into pcDNA3-Myc-His (Invitorgen). p2XAP-1-Luc, a reporter plasmid containing two copies of the AP-1 site from IL-8 promoter, was a gift from Dr N Mukaida. Reporter plasmids, that is, pAP-1-Luc (Stratagene) and pRL-tk-Luc (Promega), were purchased from companies. pH2R-Tax (Yamaoka et al., 1996) was a gift from Dr M Hatanaka.
Glutathione S-transferase pull-down assay GST fusion proteins were expressed in Escherichia coli and purified using glutathione-Sepharose beads (Amersham). For in vitro translation, [
35 S]methionine (Amersham)-labeled proteins were produced with TNT quick-coupled translation system (Promega). In vitro-translated proteins and either GST fusion protein or GST protein were incubated in 500 ml of GST-binding buffer (20 mM Tris-HCl (pH 8.0), 0.5% Nonidet P-40, 100 mM NaCl, 1 mM EDTA, 1 mM dithiothreitol, 10% glycerol, 1 mM phenylmethylsulfonyl fluoride (PMSF), and protease inhibitor cocktail (Complete EDTA-free, Roche)) at 41C for 4 h. After washing the beads with GST-binding buffer three times, bound proteins were eluted by boiling for 10 min in 1 Â sample buffer (62.5 mM Tris-HCl (pH 6.8), 2% SDS, 10% glycerol, and 5% 2-mercaptoethanol). Pull-down complexes were resolved by SDS-PAGE and autoradiographed with an image analyser BAS-2000 (Fujix) .
Immunofluorescence analysis
HeLa cells were seeded on an eight-well chamber slide (7.5 Â 10 3 cells/well) and transfected with expression plasmids by using FuGene6 (Roche). At 36 h, cells were fixed in 4% formaldehyde in phosphate-buffered saline (PBS), and permeabilized in 0.1% Triton X-100 in PBS at room temperature for 5 min. After blocking with 3% bovine serum albumin (BSA) in PBS for 1 h, cells were incubated with anti-Flag antibody (rabbit polyclonal antibody; Sigma) at room temperature for 1 h. After washing with PBS four times, samples were incubated with 4,6-diamidino-2-phenylindole (DAPI) together with rhodamine-conjugated goat anti-rabbit or anti-mouse antibody (Molecular Probes) at room temperature for 30 min. After washing, cells were mounted in 90% glycerol in PBS containing 0.01% p-phenylenediamine and observed with an immunofluorescence microscope (Zeiss).
Luciferase assay
HEK-293T cells were plated on 12-well plates (5 Â 10 4 cells/ well). After 24 h, cells were transfected with expression plasmids and further incubated for 24 h. Luciferase activities were analysed with the dual luciferase reporter assay system (Promega). Jurkat cells (2 Â 10 6 cells) were plated on six-well plates, and plasmids were transfected with Lipofectamine 2000 (Invitrogen). After 24 h, cell lysates were subjected to measurement of luciferase activities.
DNA affinity precipitation assay 5 0 -biotinylated oligonucleotide including the AP-1 site (5 0 -CGCTTGATGACTCAGCCGGAA-3 0 ) was annealed with its complementary oligonucleotide. Double-stranded oligonucleotide (1 mM) was incubated with in vitro-translated c-Jun proteins in the presence of purified GST or GST-HBZ-C in 500 ml of binding buffer (20 mM Hepes-KOH (pH 7.5), 60 mM KCl, 5 mM MgCl 2 , 0.25% Triton X-100, 0.5 mM EDTA, 1 mM dithiothreitol, and 10 mg/ml poly(dI-dC) (Amersham)) at 41C for 2 h. Streptavidin resin (Sigma) was added to the mixture and further incubated for 30 min. The resin was washed with binding buffer three times, and bound proteins were eluted by boiling for 10 min in 1 Â sample buffer. Samples were resolved by SDS-PAGE and analysed by immunoblot.
Immunoprecipitation
HEK-293T cells were plated on 6-cm dishes (5 Â 10 5 cells/dish). After 24 h, cells were transfected with appropriate plasmids. At 36-h post-transfection, these cells were solubilized in lysis buffer (50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 1 mM EDTA, 1% Nonidet P-40, 1 mM dithiothreitol, 1 mM PMSF, and protease inhibitor) at 41C for 30 min. Cell lysates were precleared with protein-G-Sepharose (Amersham) and the supernatant was incubated with 2 mg of anti-Flag antibody (M2, Sigma) at 41C for 1 h. Immunocomplexes were recovered by protein-G-Sepharose for 30 min and the resin was washed five times with 500 ml of lysis buffer. Bound proteins were eluted by boiling for 10 min in 1 Â sample buffer and then subjected to SDS-PAGE, followed by immunoblot with anti-HA antibody.
Semiquantitative RT-PCR
Total RNA was extracted with Sepasol-RNA super I (Nacalai Tesque) according to the manufacturer's instructions. Firststrand cDNA was synthesized with Superscript III (Invitrogen) using 2 mg of total RNA with oligo(dT) primer in 20 ml of reaction volume. PCR was performed using 1 ml of the reaction mixture in 10 ml of PCR buffer containing 200 mM dNTP mix, 2 mM of each set of primer, 0.2 U Taq polymerase (Promega), and 1 Â Taq buffer (Promega) at 941C for 20 s, 551C for 10 s, and 721C for 30 s. The sequences of the primers used are as follows: HA-c-Jun, 5 0 -AGAGAGCTCTTCTGATGAAGA GG-3 0 (c-Jun, forward) and 5 0 -ATTTAGGTGACACTATA GAATAG-3 0 (SP-6, reverse); human GAPDH, 5 0 -ATGGGG AAGGTGAAGGTCGG-3 0 (forward) and 5 0 -TGGAGGGA TCTCGCTCCTGG-3 0 (reverse). An aliquot of PCR products was electrophoresed on 3% agarose gel containing ethidium bromide and detected by UV-illumination. 
